255 related articles for article (PubMed ID: 30545446)
1. Survival After Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy.
Batzner A; Pfeiffer B; Neugebauer A; Aicha D; Blank C; Seggewiss H
J Am Coll Cardiol; 2018 Dec; 72(24):3087-3094. PubMed ID: 30545446
[TBL] [Abstract][Full Text] [Related]
2. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
Seggewiss H; Gleichmann U; Faber L; Fassbender D; Schmidt HK; Strick S
J Am Coll Cardiol; 1998 Feb; 31(2):252-8. PubMed ID: 9462563
[TBL] [Abstract][Full Text] [Related]
3. [Long-term outcome of patients with hypertrophic obstructive cardiomyopathy post percutaneous transluminal septal ablation].
Zheng SW; Shi HY; Dai JJ; Chen H; Wu WH; Qiu XB
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Apr; 48(4):294-301. PubMed ID: 32370480
[No Abstract] [Full Text] [Related]
4. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy: long term follow up of the first series of 25 patients.
Faber L; Meissner A; Ziemssen P; Seggewiss H
Heart; 2000 Mar; 83(3):326-31. PubMed ID: 10677415
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Rigopoulos A; Welge D; Ziemssen P; Faber L
Clin Res Cardiol; 2007 Dec; 96(12):856-63. PubMed ID: 17891517
[TBL] [Abstract][Full Text] [Related]
6. Low occurrence of ventricular arrhythmias after alcohol septal ablation in high-risk patients with hypertrophic obstructive cardiomyopathy.
Rigopoulos AG; Daci S; Pfeiffer B; Papadopoulou K; Neugebauer A; Seggewiss H
Clin Res Cardiol; 2016 Nov; 105(11):953-961. PubMed ID: 27270758
[TBL] [Abstract][Full Text] [Related]
7. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience.
Kuhn H; Lawrenz T; Lieder F; Leuner C; Strunk-Mueller C; Obergassel L; Bartelsmeier M; Stellbrink C
Clin Res Cardiol; 2008 Apr; 97(4):234-43. PubMed ID: 18071624
[TBL] [Abstract][Full Text] [Related]
8. [Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results in 66 patients with reference to myocardial contrast echocardiography].
Faber L; Seggewiss H; Fassbender D; Bogunovic N; Strick S; Schmidt HK; Gleichmann U
Z Kardiol; 1998 Mar; 87(3):191-201. PubMed ID: 9586154
[TBL] [Abstract][Full Text] [Related]
9. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a systematic review of published studies.
Alam M; Dokainish H; Lakkis N
J Interv Cardiol; 2006 Aug; 19(4):319-27. PubMed ID: 16881978
[TBL] [Abstract][Full Text] [Related]
10. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
Guo H; Wang J; Chen J; Shan J; Lee JD; Ueda T
Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
[TBL] [Abstract][Full Text] [Related]
11. Percutaneous transluminal septal ablation in hypertrophic obstructive cardiomyopathy.
Seggewiss H; Faber L; Gleichmann U
Thorac Cardiovasc Surg; 1999 Apr; 47(2):94-100. PubMed ID: 10363608
[TBL] [Abstract][Full Text] [Related]
12. Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: A 16-Year Australian Single Centre Experience.
Nogic J; Koh Y; Bak M; Gooley RP; Meredith IT; McCormick LM
Heart Lung Circ; 2018 Dec; 27(12):1446-1453. PubMed ID: 29129561
[TBL] [Abstract][Full Text] [Related]
13. Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery.
Qin JX; Shiota T; Lever HM; Kapadia SR; Sitges M; Rubin DN; Bauer F; Greenberg NL; Agler DA; Drinko JK; Martin M; Tuzcu EM; Smedira NG; Lytle B; Thomas JD
J Am Coll Cardiol; 2001 Dec; 38(7):1994-2000. PubMed ID: 11738306
[TBL] [Abstract][Full Text] [Related]
14. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response.
Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
Clin Res Cardiol; 2007 Dec; 96(12):864-73. PubMed ID: 17891518
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical follow-up of patients undergoing percutaneous alcohol septal reduction for symptomatic obstructive hypertrophic cardiomyopathy.
Fortunato de Cano S; Nicolas Cano M; de Ribamar Costa J; Alves Pinheiro J; Bellio de Mattos Barretto R; Costa de Souza Le Bihan D; Abizaid A; Sousa A; Eduardo Sousa J
Catheter Cardiovasc Interv; 2016 Nov; 88(6):953-960. PubMed ID: 27143093
[TBL] [Abstract][Full Text] [Related]
16. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy - 8 years follow up.
Sathyamurthy I; Nayak R; Oomman A; Subramanyan K; Kalarical MS; Mao R; Ramachandran P
Indian Heart J; 2014; 66(1):57-63. PubMed ID: 24581097
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.
Tsuchikane E; Takeda Y; Kobayashi T; Yachiku K; Nasu K; Kobayashi Y; Matsumoto H; Awata N
Circ J; 2003 Sep; 67(9):763-7. PubMed ID: 12939552
[TBL] [Abstract][Full Text] [Related]
18. Outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Sorajja P; Valeti U; Nishimura RA; Ommen SR; Rihal CS; Gersh BJ; Hodge DO; Schaff HV; Holmes DR
Circulation; 2008 Jul; 118(2):131-9. PubMed ID: 18591440
[TBL] [Abstract][Full Text] [Related]
19. Risk marker profiles in patients treated with percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
Burghardt A; van Buuren F; Dimitriadis Z; GrĂ¼bbel T; Seggewiss H; Scholtz S; Horstkotte D; Faber L
Clin Res Cardiol; 2018 Jun; 107(6):479-486. PubMed ID: 29453593
[TBL] [Abstract][Full Text] [Related]
20. Percutaneous transluminal septal myocardial ablation in drug-resistant hypertrophic obstructive cardiomyopathy: 18-month follow-up results.
Oomman A; Ramachandran P; Subramanyan K; Kalarickal MS; Osman MN
J Invasive Cardiol; 2001 Jul; 13(7):526-30. PubMed ID: 11435640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]